[TENAGA] QoQ Cumulative Quarter Result on 30-Nov-2012 [#1]

Announcement Date
23-Jan-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Aug-2013
Quarter
30-Nov-2012 [#1]
Profit Trend
QoQ- -67.91%
YoY- 2010.26%
View:
Show?
Cumulative Result
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
Revenue 37,130,700 27,628,500 17,981,000 9,130,800 35,848,400 26,513,600 17,322,600 66.01%
PBT 5,925,100 5,707,000 3,607,600 2,002,600 5,821,100 4,464,700 3,484,400 42.32%
Tax -542,300 -1,230,700 -930,700 -587,200 -1,402,000 -1,112,800 -817,400 -23.87%
NP 5,382,800 4,476,300 2,676,900 1,415,400 4,419,100 3,351,900 2,667,000 59.50%
-
NP to SH 5,356,200 4,442,400 2,687,600 1,415,500 4,410,500 3,349,500 2,677,100 58.57%
-
Tax Rate 9.15% 21.56% 25.80% 29.32% 24.08% 24.92% 23.46% -
Total Cost 31,747,900 23,152,200 15,304,100 7,715,400 31,429,300 23,161,700 14,655,600 67.18%
-
Net Worth 37,215,604 34,928,055 33,661,197 33,138,447 34,659,433 32,748,460 34,996,579 4.17%
Dividend
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
Div 1,393,008 553,710 551,642 - 1,097,758 277,816 277,767 192.12%
Div Payout % 26.01% 12.46% 20.53% - 24.89% 8.29% 10.38% -
Equity
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
Net Worth 37,215,604 34,928,055 33,661,197 33,138,447 34,659,433 32,748,460 34,996,579 4.17%
NOSH 5,572,032 5,537,104 5,516,420 5,505,640 5,464,202 5,458,076 5,457,130 1.39%
Ratio Analysis
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
NP Margin 14.50% 16.20% 14.89% 15.50% 12.33% 12.64% 15.40% -
ROE 14.39% 12.72% 7.98% 4.27% 12.73% 10.23% 7.65% -
Per Share
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
RPS 666.38 498.97 325.95 165.84 656.06 485.77 317.43 63.73%
EPS 96.13 80.23 48.72 25.71 80.71 61.37 49.06 56.39%
DPS 25.00 10.00 10.00 0.00 20.09 5.09 5.09 188.10%
NAPS 6.679 6.308 6.102 6.019 6.343 6.00 6.413 2.73%
Adjusted Per Share Value based on latest NOSH - 5,505,640
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
RPS 641.59 477.40 310.70 157.77 619.43 458.13 299.32 66.01%
EPS 92.55 76.76 46.44 24.46 76.21 57.88 46.26 58.57%
DPS 24.07 9.57 9.53 0.00 18.97 4.80 4.80 192.11%
NAPS 6.4305 6.0353 5.8164 5.726 5.9888 5.6586 6.0471 4.17%
Price Multiplier on Financial Quarter End Date
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
Date 30/08/13 31/05/13 28/02/13 30/11/12 30/08/12 31/05/12 29/02/12 -
Price 8.73 8.35 6.94 6.94 6.84 6.67 6.28 -
P/RPS 1.31 1.67 2.13 4.18 1.04 1.37 1.98 -24.01%
P/EPS 9.08 10.41 14.24 26.99 8.47 10.87 12.80 -20.41%
EY 11.01 9.61 7.02 3.70 11.80 9.20 7.81 25.64%
DY 2.86 1.20 1.44 0.00 2.94 0.76 0.81 131.34%
P/NAPS 1.31 1.32 1.14 1.15 1.08 1.11 0.98 21.28%
Price Multiplier on Announcement Date
31/08/13 31/05/13 28/02/13 30/11/12 31/08/12 31/05/12 29/02/12 CAGR
Date 31/10/13 18/07/13 18/04/13 23/01/13 31/10/12 19/07/12 12/04/12 -
Price 9.43 9.01 7.95 6.96 6.95 6.75 6.51 -
P/RPS 1.42 1.81 2.44 4.20 1.06 1.39 2.05 -21.66%
P/EPS 9.81 11.23 16.32 27.07 8.61 11.00 13.27 -18.19%
EY 10.19 8.90 6.13 3.69 11.61 9.09 7.54 22.16%
DY 2.65 1.11 1.26 0.00 2.89 0.75 0.78 125.49%
P/NAPS 1.41 1.43 1.30 1.16 1.10 1.13 1.02 24.01%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment